WCLC 2025 - Posters & ePosters-P2.02.20 Targeting BTN1A1 in Pd=D-L1-Negative NSCLC: A Clinically Actionable Immune Checkpoint for Docetaxel-Based Combination Therapy

P2.02.20 Targeting BTN1A1 in Pd=D-L1-Negative NSCLC: A Clinically Actionable Immune Checkpoint for Docetaxel-Based Combination Therapy

Asset Subtitle

Stephen Yoo

Meta Tag

Speaker Stephen Yoo

Topic Tumor Biology – Preclinical Biology